Cargando…

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial

BACKGROUND: Data on belimumab efficacy in patients with lupus nephritis (LN) according to diagnosis duration or induction therapy are limited. Post hoc analyses of the phase 3, randomized, double-blind BLISS-LN study (GSK BEL114054; NCT01639339) were performed to assess belimumab efficacy on kidney-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anders, Hans-Joachim, Furie, Richard, Malvar, Ana, Zhao, Ming-Hui, Hiromura, Keiju, Weinmann-Menke, Julia, Green, Yulia, Jones-Leone, Angela, Negrini, Daniela, Levy, Roger A, Lightstone, Liz, Tanaka, Yoshiya, Rovin, Brad H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689192/ https://www.ncbi.nlm.nih.gov/pubmed/37463054 http://dx.doi.org/10.1093/ndt/gfad167

Ejemplares similares

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study
por: van Vollenhoven, Ronald F, et al.
Publicado: (2018)

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
por: Lokhandwala, Tasneem, et al.
Publicado: (2021)

This, This Is Bliss
Publicado: (1882)

De novo lupus nephritis during treatment with belimumab
por: Parodis, Ioannis, et al.
Publicado: (2020)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol
por: Teng, Y K Onno, et al.
Publicado: (2019)

Efficacy of novel monoclonal antibody belimumab in the treatment of lupus nephritis
por: Frieri, Marianne, et al.
Publicado: (2015)

Belimumab in Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Shrestha, Sanjeev, et al.
Publicado: (2021)

Urine proteomic insights from the belimumab in lupus nephritis trial
por: Weeding, Emma, et al.
Publicado: (2022)

Shadows of Bliss
por: CERN. Geneva, et al.
Publicado: (1972)

The Bliss of Madness
por: Jameson, Richard
Publicado: (1972)

Prohibited Bliss
Publicado: (1886)

Bliss & Sharp
Publicado: (1868)

Treatment Using Both Voclosporin and Belimumab in Four Patients With Lupus Nephritis
por: Baum, Rebecca, et al.
Publicado: (2023)

Molecular characterization of proliferative lupus nephritis
por: Parikh, Samir V, et al.
Publicado: (2014)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis
por: D’Alessandro, Roberto, et al.
Publicado: (2021)

Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
por: Furie, Richard, et al.
Publicado: (2014)

Dialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease
por: Schober, Fernanda Payan, et al.
Publicado: (2015)

Essays in Honour of Michael Bliss
por: Zadorozny, Christine
Publicado: (2009)

Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis
por: Zhang, Han, et al.
Publicado: (2023)

Effect of Belimumab on Preventing de novo Renal Lupus Flares
por: Parodis, Ioannis, et al.
Publicado: (2023)

Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programme
por: Maslen, Toni, et al.
Publicado: (2021)

Clinical response to belimumab in academic clinical practices
por: Reddy, Arthi, et al.
Publicado: (2014)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China
por: Tan, Meng, et al.
Publicado: (2023)

B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial
por: Furie, Richard A, et al.
Publicado: (2022)

BLISS: an artificial language for learnability studies
por: Pirmoradian, Sahar, et al.
Publicado: (2011)

Mr. Bliss's Observations on the Kilburn Water
por: Bliss, John
Publicado: (1801)

Lamotrigine Drug Interactions: Ignorance is not Bliss
por: Armstrong, Austin G., et al.
Publicado: (2022)

Henry Bliss Noble, D.D.S.
Publicado: (1902)

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials
por: Strand, Vibeke, et al.
Publicado: (2014)

BLISS: Shining a light on lignification in plants
por: Simon, Clémence, et al.
Publicado: (2017)

Ignorance may be Bliss (for Intensivists), but not for ICU Patients!
por: Bakshi, Sumitra G, et al.
Publicado: (2019)

Airway Obstruction by Transesophageal Echocardiography: Is Oblivion Bliss?
por: Sun, Terri, et al.
Publicado: (2020)

Insular Stimulation Produces Mental Clarity and Bliss
por: Nencha, Umberto, et al.
Publicado: (2021)

Dr. Bliss’ Report of President Garfield’s Case
Publicado: (1881)

Ignorance is bliss? Information and risk on crowdfunding platforms
por: D’Arcangelo, Chiara, et al.
Publicado: (2023)

MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT
por: Sada, Kenei, et al.
Publicado: (2022)

Psychometric properties of FACIT-Fatigue in systemic lupus erythematosus: a pooled analysis of three phase 3 randomised, double-blind, parallel-group controlled studies (BLISS-SC, BLISS-52, BLISS-76)
por: Rendas-Baum, Regina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i14a279040v7pt7st242c80dea